Provided by Tiger Trade Technology Pte. Ltd.

INCANNEX HEALTHCARE LTD

0.2880
+0.038015.20%
Post-market: 0.29000.0020+0.69%19:59 EST
Volume:8.61M
Turnover:2.40M
Market Cap:100.22M
PE:-0.27
High:0.3000
Open:0.2617
Low:0.2558
Close:0.2500
52wk High:2.20
52wk Low:0.0800
Shares:348.00M
Float Shares:89.88M
Volume Ratio:1.09
T/O Rate:9.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0800
EPS(LYR):-1.3608
ROE:-114.52%
ROA:-30.33%
PB:1.30
PE(LYR):-0.21

Loading ...

Incannex Healthcare Expands Clinical Advisory Board With Three New Appointments

Reuters
·
Jan 29

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

THOMSON REUTERS
·
Jan 29

Incannex Healthcare Announces Formation of Clinical Advisory Board for Psx-001 Program

THOMSON REUTERS
·
Jan 22

Incannex Healthcare Inc. Held Annual Stockholder Meeting

Reuters
·
Jan 16

Incannex Wins R&D Award for Oral Obstructive Sleep Apnea Therapy

Reuters
·
Jan 15

BRIEF-Incannex Healthcare Delivers Transformational 2025 Progress And Outlines Well-Funded Outlook For 2026

Reuters
·
Jan 14

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

THOMSON REUTERS
·
Jan 14

Incannex Healthcare Raises $12.5 Million in Private Placement

Reuters
·
Jan 14

BUZZ-U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox

Reuters
·
Dec 04, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Microsoft, Wyndham Hotels & Resorts, Daktronics

Reuters
·
Dec 03, 2025

FDA Grants Fast Track Designation to Incannex Healthcare for IHL-42X in Obstructive Sleep Apnea

Reuters
·
Dec 03, 2025

Incannex Granted FDA Fast Track Designation for Ihl-42X in Obstructive Sleep Apnea (Osa)

THOMSON REUTERS
·
Dec 03, 2025

Incannex Healthcare reports Phase 2 data showing IHL-42X reduces AHI in obstructive sleep apnoea

Reuters
·
Nov 20, 2025

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and Eoy 2025 Strategic Focus

THOMSON REUTERS
·
Oct 30, 2025

Incannex Healthcare Inc. Announces Date for Upcoming Annual Meeting of Stockholders

Reuters
·
Oct 28, 2025

BRIEF-Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Reuters
·
Oct 22, 2025

Incannex Healthcare Faces Nasdaq Delisting Risk Over Low Share Price

Reuters
·
Oct 22, 2025

Incannex Healthcare Reports Fiscal 2025 Revenue Up 617% to $86,000; Net Loss Widens to $46.9 Million

Reuters
·
Sep 30, 2025

US Listed Shares of Incannex Healthcare Rise 18.7% After Co's Anxiety Treatment Meets Mid-Stage Trial Goal

THOMSON REUTERS
·
Aug 26, 2025

Incannex Healthcare Announces Positive Phase 2 Trial Results for Psilocybin-Assisted Therapy PSX-001 in Treating Generalised Anxiety Disorder

Reuters
·
Aug 26, 2025